Babler Martin
Director at NGNE; President, CEO at Principia Biopharma Inc.
- Sold, on record
- $3.4M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jun 23, 2020
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- NGNENeurogene Inc.Director
- Principia Biopharma Inc.President, CEO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Principia Biopharma Inc.UnusualDec 18, 2019 2019
Sold 29,500 shares at $53.07 ($1.6M)
Babler Martin, President, CEO
Sold 65.3% of holdings ($2.4M position)15,696 shares leftFirst sale on recordFiling
- 2 Form 4 sale Principia Biopharma Inc.UnusualMar 3, 2020 +76 days
Sold 15,000 shares at $63.47 ($952k)
Babler Martin, President, CEO
Sold 27.7% of holdings ($3.4M position)39,179 shares leftFiling
- 3 Form 4 sale Principia Biopharma Inc.UnusualJun 23, 2020 +112 days
Sold 15,000 shares at $61.86 ($928k)
Babler Martin, President, CEO
Sold 94.9% of holdings ($978k position)810 shares leftFiling
- 4 Form 144 notice NGNENoticeMar 7, 2024 +1353 days
Filed to sell 2,500 shares ($98k)
Babler Martin, Director
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Mar 7, 2024 | NGNE | Director | Form 144 notice | 2,500 | $98k | Notice | SEC | |
| Jun 23, 2020 | Jun 25, 2020 | Principia Biopharma Inc. | President, CEO | Form 4 sale | 15,000 | $928k | 94.9% | Unusual | SEC |
| Mar 3, 2020 | Mar 5, 2020 | Principia Biopharma Inc. | President, CEO | Form 4 sale | 15,000 | $952k | 27.7% | Unusual | SEC |
| Dec 18, 2019 | Dec 19, 2019 | Principia Biopharma Inc. | President, CEO | Form 4 sale | 29,500 | $1.6M | 65.3% | Unusual | SEC |